Core Viewpoint - Wanrun Co., Ltd. announced that its subsidiary, Yantai Jiumu Chemical Co., Ltd. (Jiumu Chemical), has received the acceptance notice from the Beijing Stock Exchange for its application to publicly issue shares and list on the exchange [1][3]. Company Overview - Wanrun Co., Ltd. holds 85 million shares of Jiumu Chemical, representing a 45.33% stake, making it the controlling shareholder [3]. - Jiumu Chemical, established in 2005, specializes in the research, production, and sales of OLED front-end materials and is recognized as a national key specialized and innovative "little giant" enterprise [4]. - Wanrun Co., Ltd. operates in four main sectors: environmental materials, electronic information materials, new energy materials, and life sciences and pharmaceuticals [4]. Financial Performance - Jiumu Chemical's revenue from 2022 to Q1 2025 was 706 million yuan, 878 million yuan, 962 million yuan, and 208 million yuan, respectively, with net profits of 197 million yuan, 203 million yuan, 246 million yuan, and 46 million yuan [5]. - The company has increased its R&D investment from 58.78 million yuan in 2022 to 83.03 million yuan in 2024, with R&D expenses accounting for 8.33%, 7.47%, and 8.63% of revenue in the respective years [5]. Market Position and Industry Outlook - Jiumu Chemical is expected to capture approximately 23% of the global OLED front-end materials market in 2024 [4]. - The demand for OLED front-end materials is anticipated to grow due to the increasing market penetration of OLED panels in consumer electronics such as smartphones and smart home products [4]. - Jiumu Chemical's overseas sales accounted for 92.69% of its main business revenue in 2024, with key markets including South Korea, Germany, and Japan [5]. Customer Concentration Risk - The company has a high customer concentration risk, with sales to its top five customers accounting for 72.93%, 71.40%, and 77.45% of its revenue from 2022 to 2024 [5].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company reported a significant quarter-on-quarter increase in performance, with Q2 revenue reaching 1.009 billion yuan, a year-on-year decrease of 1% but a quarter-on-quarter increase of 17.1%. The net profit attributable to the parent company for Q2 was 138 million yuan, showing a year-on-year increase of 18.3% and a quarter-on-quarter increase of 73.1% [4][5] - The company is expected to gradually grow into a new materials platform enterprise driven by research and innovation, leading to an upward revision of profit forecasts for 2025-2027 [4] Financial Performance Summary - For the first half of 2025, the company achieved a revenue of 1.469 billion yuan in functional materials and 376 million yuan in life sciences and pharmaceuticals, with year-on-year changes of -9.55% and +20.80% respectively [5] - The gross profit margin for the first half of 2025 was 38.68% for functional materials and 38.56% for life sciences, with changes of -1.99 and +1.36 percentage points year-on-year [5] - The company’s total revenue for 2025 is projected to be 4.022 billion yuan, with a net profit of 461 million yuan, reflecting a year-on-year growth of 87.2% [7] - The company’s gross margin and net margin for the mid-2025 report were 38.75% and 14.44%, respectively, compared to the previous year’s report [5] Business Development - The company is actively expanding its product lines, including semiconductor manufacturing materials and polyimide materials, and is making progress in the development of PEEK and high-temperature nylon [5] - The company has initiated the second phase of the Wanrun Industrial Park project, with an investment of 287 million yuan aimed at expanding production capacity for photolithography materials and display polyimide materials [5] - The company’s subsidiaries, such as San Yue Technology and MP, have reported revenue growth and profitability improvements, while Jiuyue Chemical experienced a decline in revenue and net profit due to order distribution [5][9]